Post-septic encephalopathy is a poorly understood condition in survivors of sepsis that is characterised by cognitive and affective impairments. In this study we have sought to better understand this condition by undertaking a comprehensive behavioural and cognitive assessment of mice who had previously survived sepsis. Mice were treated with lipopolysaccharide (LPS; 5 mg/kg) and one month after this assessed on a battery of tests. Post-septic animals were found to display significantly more immobility in the tail suspension test and show a significantly decreased sucrose preference. Acute fluoxetine treatment reversed the increase in immobility in the tail suspension test in post-septic animals. Post-septic animals also showed less overall exploratory behaviour in the novel object recognition task and also showed increased anxiety-like behaviour in the elevated plus maze. Post-septic mice did not show signs of cognitive impairment, as assessed in the Morris watermaze, the 8-arm radial maze or on preference for the novel object in the novel object recognition task. Immunohistochemical analysis revealed significant upregulation of the microglial marker CD-11b, F4/80 and IBA-1 in the hippocampus of post-septic animals, as well as significant downregulation of the plasticity-related immediate early gene products ARC and EGR1. We also observed a decrease in neural stem cell proliferation in the dentate gyrus of post-septic animals as judged by BrdU incorporation. Co-treatment with the NF-jB pathway inhibitor PDTC attenuated the long-lasting effects of LPS on most of the affected parameters, but not on neural stem cell proliferation. These results show that LPS-induced sepsis in the mouse is followed by longlasting increases in depressive-and anxiety-like behaviours, as well as by changes in neuroinflammatoryand neural plasticity-associated factors, and that attenuation of the severity of sepsis by PDTC attenuates many of these effects.
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Introduction
Sepsis refers to a severe inflammatory response to infection co-occurring with alterations in at least two of the following parameters -body temperature, heart rate, respiratory rate and white blood cell count (Robertson and Coopersmith, 2006) . Septic encephalopathy is a common complication of sepsis, occurring in up to 70% of patients (Papadopoulous et al., 2000) involving a deleterious mental state ranging from confusion to coma (Jacob et al., 2011) . Structural and neuroinflammatory alterations persist in survivors, including reduced hippocampal volume and altered EEG activity, leading to cognitive and psychological impairments for years following recovery, and this condition is termed post-septic encephalopathy (Lazosky et al., 2010; Iwashyna et al., 2010; Davydow et al., 2012; Semmler et al., 2013; Winters et al., 2010; Ziaja, 2013) . The aetiology of post-septic encephalopathy is not well understood and there are currently no successful treatments available.
While sepsis in humans is a heterogeneous condition, it is often modelled in rodents using the intraperitoneal injection of a high dose of the bacterial endotoxin lipopolysaccharide (LPS; Buras et al., 2005; Doi et al., 2009) . Peripheral administration of highdose LPS leads to a potent inflammatory response, via TLR-4 binding and subsequent NF-jB pathway activation. These LPS treatments mimic many of the clinical features of sepsis and results in a hyper-inflammatory response, accompanied by depressed EEG rhythmicity, low blood pressure, oxidative stress, multiple organ failure and a significant mortality rate (Chang et al., 2013; Lin et al., 2010; Okazaki et al., 2014) . Following recovery from the acute effects of LPS-induced sepsis, an increased level microglial activation persists in the CNS, accompanied by
